Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 30, 1999
A simplified CT-based definition of the lymph node levels in the node negative neck
O B Wijers, P C Levendag, T Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2010
A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer
S Senan, F Cardenal, J Vansteenkiste, et al.
JTO Clinical and Research Reports
|
March 27, 2023
Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors
S Ünal, J A Winkelman, D J Heineman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Novello, F Barlesi, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crinò, C Dooms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer
J G J V Aerts, V Surmont, R J van Klaveren, et al.
ESMO Open
|
March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
S Senan, M Özgüroğlu, D Daniel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2017
Identifying barriers to accrual in radiation oncology randomized trials
J M Laba, S Senan, D Schellenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 30, 1999
A simplified CT-based definition of the lymph node levels in the node negative neck
O B Wijers, P C Levendag, T Tan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2010
A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer
S Senan, F Cardenal, J Vansteenkiste, et al.
JTO Clinical and Research Reports
|
March 27, 2023
Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors
S Ünal, J A Winkelman, D J Heineman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2016
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Novello, F Barlesi, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crinò, C Dooms, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer
J G J V Aerts, V Surmont, R J van Klaveren, et al.
ESMO Open
|
March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
S Senan, M Özgüroğlu, D Daniel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Critical factors for patient management
V Ninane, C Le Pechoux, W Curran, et al.
Current Oncology (Toronto, Ont.)
|
December 23, 2017
Identifying barriers to accrual in radiation oncology randomized trials
J M Laba, S Senan, D Schellenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Page
of 10